secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001104659-24-096362
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics subsidiary receives default suspension, but no waiver
-------------------------------------------------------------------------

- On August 29, 2024, ImmunogenX received letter from Lender Mattress Liquidators suspending MAE Default under Credit Agreement.
- Original Notice of Default was received on August 2, 2024, alleging Material Adverse Effect and accelerating all obligations.
- Lender's suspension is not a waiver; all rights regarding enforcement of MAE Default are expressly reserved.
- No principal amount or financial impact disclosed in filing; discussions are ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/0001104659-24-096362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/tm2423257d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-096362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer